Tx escabiasis menores de 2 meses

Management of Scabies in Infants Younger Than 2 Months

TAKE-HOME MESSAGE

• The authors of this descriptive study surveyed 57 physicians, primarily with pediatric dermatology board certification (84.2%), on practices in treating scabies infections in infants less than 2 months old. Most respondents had experience using topical permethrin (82.5%) and precipitated sulfur (61.4%) in patients younger than 2 months. Permethrin was preferred by most providers (38/57); only 4.3% of those who had used it had encountered side effects, which included itching, erythema, and xerosis.

• There are limited data on the safety of topical permethrin in infants younger than 2 months; it is FDA approved for use in infants aged 2 months and older. This study demonstrated, however, that most respondents felt comfortable using it in this context for younger infants, and adverse effects were encountered infrequently.

– Margaret Hammond, MD

Abstract 

BACKGROUND/OBJECTIVES

Efficacy and safety data of scabies treatments in infants are limited. Although topical permethrin is used in the treatment of scabies in adults, it is not approved for use in infants younger than 2 months of age in many parts of the world. This study aimed to describe treatment practices in the management of scabies in infants younger than 2 months.

METHODS

An online survey was developed and distributed to physicians worldwide through the Society of Pediatric Dermatology and the Pediatric Dermatology Research Alliance. Data collected included demographics, medication availability, experience using medications, deterrents to medication use, medication administration preferences, perceived and experienced medication side effects, and preferred treatment agent in this population.

RESULTS

In total, 57 physicians from seven countries responded. The majority of respondents were board-certified in pediatric dermatology (48/57, 84.2%) and resided in the United States (44/57, 77.2%). Respondents had experience using permethrin (47/57, 82.5%) and precipitated sulfur (35/57, 61.4%) most frequently. Most (38/57, 66.7%) preferred permethrin as their treatment of choice. Among those who did not use permethrin, potential side effects (8/10, 80%) were most frequently reported as a deterrent from its use. However, only 4.3% (22/47) of those who used permethrin reported side effects, including itching, erythema, and xerosis.

CONCLUSIONS

Permethrin is frequently used in the treatment of infants younger than 2 months with scabies. Furthermore, our results demonstrate that permethrin is the preferred treatment agent among sampled dermatologists for infants younger than 2 months. Few side effects were reported, and none were serious.

Pediatric Dermatology

Treatment Practices in the Management of Scabies in Infants Younger Than Two Months

Pediatr Dermatol 2021 Jan 24;[EPub Ahead of Print], C Thomas, W Rehmus, AY Chang 

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.